Propanc Biopharma, Inc.
PPCB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$58,923 | -$1,821 | -$2,661 | -$2,658 |
| Dep. & Amort. | $4,641 | $22 | $23 | $6 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $1,138 | $417 | $473 | $167 |
| Other Non-Cash | $52,739 | $446 | $1,060 | $1,049 |
| Operating Cash Flow | -$405 | -$935 | -$1,105 | -$1,436 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $344 | $919 | $590 | $767 |
| Stock Issued | $51,348 | $23 | $25 | $99 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $147 | $0 | $499 | $625 |
| Financing Cash Flow | $491 | $942 | $1,114 | $1,491 |
| Forex Effect | -$95 | $4 | -$2 | -$53 |
| Net Chg. in Cash | -$9 | $11 | $6 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $10 | $4 | $2 |
| End Cash | $12 | $21 | $10 | $4 |
| Free Cash Flow | -$405 | -$935 | -$1,105 | -$1,436 |